News
-
Generics opt-out flagged
Wednesday | May 3 2017NEXT week's federal budget will see significant changes to the way medications are prescribed in Australia, with generic versions of drugs to be the default option in doctors prescribing software.
-
May PBS additions
Tuesday | May 2 2017HEALTH minister Greg Hunt yesterday confirmed the addition of "$310 million of new vital drugs" to the Pharmaceutical Benefits Scheme, with new items including Kalydeco (ivacaftor) for children aged 2-5 with cystic fibrosis.
-
New MSD biosimilar
Tuesday | May 2 2017RENFLEXIS from the MSD stable is the second infliximab biosimilar to be given TGA approval, and the company is planning a hospital launch of the product in 2017.
-
Winter is (nearly) here
Tuesday | May 2 2017TODAY'S issue of Pharmacy Daily features our newest Spotlight supplement, with details of several products ideal for winter sales included on page three.
-
Mayne loses $200m
Tuesday | May 2 2017MAYNE Pharma shares fell almost 11% on Mon, wiping around $200m from its market capitalisation, following a revelation that sales for its Teva suite of US generic products would not meet forecasts.
-
$10m for myDNA
Tuesday | May 2 2017MELBOURNE-BASED myDNA has raised $10 million in its latest round of capital raising, which has included the backing of Swisse ceo Radek Sali who is joining the genetics company's board.
-
DAA services PSA review
Tuesday | May 2 2017THE Pharmaceutical Society of Australia (PSA) is inviting feedback on revised guidelines for Dose Administration Aid services, following a review to support the implementation of new Professional Practice Standards.
-
Code of Conduct update
Tuesday | May 2 2017THE Pharmacy Board of Australia is set to invite feedback to its Code of Conduct for pharmacists in Australia, with social media and online channels to inform the profession on how it can contribute.
-
Orphan drug reform
Tuesday | May 2 2017The TGA has published transition arrangements for the reform of its Orphan Drug Program, which is.